Page last updated: 2024-08-22

lanthanum and mtt formazan

lanthanum has been researched along with mtt formazan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Karaivanova, M; Kostova, I; Momekov, G; Zaharieva, M	1
Berger, W; Chiba, P; Dornetshuber, R; Elbling, L; Heffeter, P; Jakupec, MA; Keppler, BK; Körner, W; Micksche, M; Pirker, C; Sutterlüty, H	1

Other Studies

2 other study(ies) available for lanthanum and mtt formazan

Article	Year
Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins. European journal of medicinal chemistry, 2005, Volume: 40, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Coumarins; DNA Fragmentation; Drug Screening Assays, Antitumor; Formazans; HL-60 Cells; Humans; Inhibitory Concentration 50; Lanthanum; Lymphoma, B-Cell; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Organometallic Compounds; Spectrophotometry, Infrared; Tetrazolium Salts	2005
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Biochemical pharmacology, 2007, Jun-15, Volume: 73, Issue:12 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Formazans; HL-60 Cells; Humans; Lanthanum; Lung Neoplasms; Molecular Structure; Neoplasm Proteins; Organic Anion Transporters; Organometallic Compounds; Phenanthrolines; Sensitivity and Specificity; Tetrazolium Salts	2007

Article

Year

Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.

European journal of medicinal chemistry, 2005, Volume: 40, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Coumarins; DNA Fragmentation; Drug Screening Assays, Antitumor; Formazans; HL-60 Cells; Humans; Inhibitory Concentration 50; Lanthanum; Lymphoma, B-Cell; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Organometallic Compounds; Spectrophotometry, Infrared; Tetrazolium Salts

2005

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).

Biochemical pharmacology, 2007, Jun-15, Volume: 73, Issue:12

Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Small Cell; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Formazans; HL-60 Cells; Humans; Lanthanum; Lung Neoplasms; Molecular Structure; Neoplasm Proteins; Organic Anion Transporters; Organometallic Compounds; Phenanthrolines; Sensitivity and Specificity; Tetrazolium Salts

2007